-DOCSTART- -X- O
New -X- _ O
organisms -X- _ O
and -X- _ O
biological -X- _ O
systems -X- _ O
designed -X- _ O
to -X- _ O
satisfy -X- _ O
human -X- _ O
needs -X- _ O
are -X- _ O
among -X- _ O
the -X- _ O
aims -X- _ O
of -X- _ O
synthetic -X- _ B-Patient
genomics -X- _ I-Patient
and -X- _ I-Patient
synthetic -X- _ I-Patient
biology. -X- _ I-Patient
Synthetic -X- _ B-Patient
biology -X- _ I-Patient
seeks -X- _ O
to -X- _ O
model -X- _ O
and -X- _ O
construct -X- _ O
biological -X- _ B-Patient
components -X- _ I-Patient
, -X- _ O
functions -X- _ B-Patient
and -X- _ I-Patient
organisms -X- _ I-Patient
that -X- _ I-Patient
do -X- _ I-Patient
not -X- _ I-Patient
exist -X- _ I-Patient
in -X- _ I-Patient
nature -X- _ I-Patient
or -X- _ I-Patient
to -X- _ I-Patient
redesign -X- _ I-Patient
existing -X- _ I-Patient
biological -X- _ I-Patient
systems -X- _ I-Patient
to -X- _ I-Patient
perform -X- _ I-Patient
new -X- _ I-Patient
functions. -X- _ I-Patient
Synthetic -X- _ B-Patient
genomics -X- _ I-Patient
, -X- _ O
on -X- _ O
the -X- _ O
other -X- _ O
hand -X- _ O
, -X- _ O
encompasses -X- _ O
technologies -X- _ O
for -X- _ O
the -X- _ O
generation -X- _ O
of -X- _ O
chemically-synthesized -X- _ B-Intervention
whole -X- _ I-Intervention
genomes -X- _ I-Intervention
or -X- _ I-Intervention
larger -X- _ I-Intervention
parts -X- _ I-Intervention
of -X- _ I-Intervention
genomes -X- _ I-Intervention
, -X- _ O
allowing -X- _ O
to -X- _ O
simultaneously -X- _ O
engineer -X- _ O
a -X- _ O
myriad -X- _ O
of -X- _ O
changes -X- _ O
to -X- _ O
the -X- _ O
genetic -X- _ O
material -X- _ O
of -X- _ O
organisms. -X- _ O
Engineering -X- _ O
complex -X- _ O
functions -X- _ O
or -X- _ O
new -X- _ O
organisms -X- _ O
in -X- _ O
synthetic -X- _ B-Intervention
biology -X- _ I-Intervention
are -X- _ I-Intervention
thus -X- _ I-Intervention
progressively -X- _ I-Intervention
becoming -X- _ I-Intervention
dependent -X- _ I-Intervention
on -X- _ I-Intervention
and -X- _ I-Intervention
converging -X- _ I-Intervention
with -X- _ I-Intervention
synthetic -X- _ I-Intervention
genomics. -X- _ I-Intervention
While -X- _ O
applications -X- _ O
from -X- _ O
both -X- _ O
areas -X- _ O
have -X- _ O
been -X- _ O
predicted -X- _ O
to -X- _ O
offer -X- _ O
great -X- _ O
benefits -X- _ O
by -X- _ O
making -X- _ O
possible -X- _ O
new -X- _ O
drugs -X- _ O
, -X- _ O
renewable -X- _ O
chemicals -X- _ O
or -X- _ O
clean -X- _ O
energy -X- _ O
, -X- _ O
they -X- _ O
have -X- _ O
also -X- _ O
given -X- _ O
rise -X- _ O
to -X- _ O
concerns -X- _ O
about -X- _ O
new -X- _ O
safety -X- _ O
, -X- _ O
environmental -X- _ O
and -X- _ O
socio-economic -X- _ O
risks -X- _ O
â€“ -X- _ O
stirring -X- _ O
an -X- _ O
increasingly -X- _ O
polarizing -X- _ O
debate. -X- _ O
Here -X- _ O
we -X- _ O
intend -X- _ O
to -X- _ O
provide -X- _ O
an -X- _ O
overview -X- _ O
on -X- _ O
recent -X- _ O
progress -X- _ O
in -X- _ O
biomedical -X- _ B-Comparison
and -X- _ I-Comparison
biotechnological -X- _ I-Comparison
applications -X- _ I-Comparison
of -X- _ I-Comparison
synthetic -X- _ I-Comparison
genomics -X- _ I-Comparison
and -X- _ I-Comparison
synthetic -X- _ I-Comparison
biology -X- _ I-Comparison
as -X- _ O
well -X- _ O
as -X- _ O
on -X- _ O
arguments -X- _ O
and -X- _ O
evidence -X- _ O
related -X- _ O
to -X- _ O
their -X- _ O
possible -X- _ O
benefits -X- _ O
, -X- _ O
risks -X- _ O
and -X- _ O
governance -X- _ O
implications -X- _ O
. -X- _ O

